Early data on the Edwards SAPIEN 3 valve (S3-THV) have shown low rates of paravalvular leaks and vascular complications but relatively high 30-day permanent pacemaker implantation (PPMI) rates. No direct comparisons on clinical outcomes including PPMI rates are available for the S3-THV and the Edwards SAPIEN XT (XT-THV). We aimed to compare the 30-day PPMI rates in patients treated with the two prostheses and to assess the interplay among valve type, depth of implantation and PPMI rate.
Unravelling the (arte)fact of increased pacemaker rate with the Edwards SAPIEN 3 valve
TARANTINI, GIUSEPPE;MOJOLI, MARCO ALBERTO;PURITA, PAOLA ANGELA MARIA;NAPODANO, MASSIMO;D'ONOFRIO, AUGUSTO;FRIGO, ANNA CHIARA;COVOLO, ELISA;FACCHIN, MICHELA;GEROSA, GINO;ILICETO, SABINO
2015
Abstract
Early data on the Edwards SAPIEN 3 valve (S3-THV) have shown low rates of paravalvular leaks and vascular complications but relatively high 30-day permanent pacemaker implantation (PPMI) rates. No direct comparisons on clinical outcomes including PPMI rates are available for the S3-THV and the Edwards SAPIEN XT (XT-THV). We aimed to compare the 30-day PPMI rates in patients treated with the two prostheses and to assess the interplay among valve type, depth of implantation and PPMI rate.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
_issue-article_201411-06.pdf
Accesso riservato
Tipologia:
Published (Publisher's Version of Record)
Licenza:
Accesso privato - non pubblico
Dimensione
1.24 MB
Formato
Adobe PDF
|
1.24 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
